Combinations / Blended Pellets

STABICOAT’s Blended or combination drug pellets are advanced multiparticulate dosage forms designed to deliver two or more active pharmaceutical ingredients (APIs) in a single formulation. These pellets ensure uniform distribution of APIs, controlled release profiles & reduced drug–drug interaction. They enable pharmaceutical companies to develop patient-friendly fixed-dose combinations with improved compliance & therapeutic efficacy. The flexible pelletisation technology allows customization of release kinetics—immediate, sustained, or delayed—based on therapeutic requirements. Combination pellets also support enhanced bioavailability, stability & scalable manufacturing for high-volume production. They serve as an innovative platform for next-generation oral solid dosage development. Manufactured under stringent GMP compliance, these pellets enable pharmaceutical companies worldwide to develop innovative, patient-friendly formulations with reduced capsule size & improved treatment outcomes.